510(k) Report

510(k) · Cleared

Cleared

Vision Cardioplegia Delivery System

K964571510(k) TraditionalCleared Aug 8, 1997267-day reviewClass II21 CFR 870.4240

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lifestream Int'L, Inc. · DTR Heat-Exchanger, Cardiopulmonary Bypass

Cleared on Aug 8, 1997 as substantially equivalent to K925369 (Sorin Biomedica, Fiat, USA, Inc., 1993) and 1 other predicate after a 267-day review. Its family tree reaches back 1 generation to 1990.

Decided
Aug 8, 1997
Review
267 days
Class
Class II
Product code
DTR
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K904171 (1990). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1993: 1 other ancestorK904171 · Scimed Cardiotherm Cardioplegia Delivery System · Scimed · 199019901992199419961998
Other ancestors, by generation 1 generation back: 1 other ancestor K904171 · Scimed Cardiotherm Cardioplegia Delivery System · Scimed · 19900
  1. Root · 1 generation backK904171 Scimed Cardiotherm Cardioplegia Delivery SystemScimed · 1990
  2. This deviceK964571 Vision Cardioplegia Delivery SystemLifestream Int'L, Inc. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K904171Scimed Cardiotherm Cardioplegia Delivery SystemScimed1990—
0 (this device)K964571Vision Cardioplegia Delivery SystemLifestream Int'L, Inc.1997—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
FIG. 1 — Lineage of K964571, 1990–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DTR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DTR device

  1. #1 K252541 Quantum PureFlow Standard Heat Exchanger…score 13.4 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K925369BCD Advanced Blood Carioplegia Systems
Summary page 1
…legally marketed cardioplegia heat exchangers: Sorin Biomedical Buckberg BCD Vanguard (No K number identified) Sorin Biomedical BCD Advanced Blood Cardioplegia System (K925369) Avecor Cardiovascular MYOtherm Cardioplegia System (K904171) SURGIMEDICS®/TMP® Vision Cardioplegia Delivery System - 510(k) Sum…
Sorin Biomedica, Fiat, USA, Inc.1993—
*K904171Scimed Cardiotherm Cardioplegia Delivery System
Summary page 1
…ical Buckberg BCD Vanguard (No K number identified) Sorin Biomedical BCD Advanced Blood Cardioplegia System (K925369) Avecor Cardiovascular MYOtherm Cardioplegia System (K904171) SURGIMEDICS®/TMP® Vision Cardioplegia Delivery System - 510(k) Summary 11/13/96 Page 1 7. Device Description an…
Scimed1990—
*—Sorin Biomedical Buckberg BCD Vanguard
Named without a submission number
—

Also cleared against K925369: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 2 other devices also cite its predicate K925369.

How does its category compare?

All DTR devices

DTR Heat-Exchanger, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DTR

2in 2025

2008: 12009: 22017: 22018: 12020: 22022: 22023: 12024: 12025: 22026 (partial year): 1
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTR

Too few DTR 510(k)s in any year since 2007 to give a median.

Recalls per year · DTR

1in 2015

2010: 242011: 32015: 12026 (partial year): 2
2007high 24 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DTR

44in 2025

2007: 22008: 12010: 432011: 672012: 162013: 272014: 662015: 962016: 602017: 692018: 752019: 352020: 332021: 112022: 232023: 182024: 82025: 44
2007high 96 (2015) · low 0 (2009)2025

MAUDE reports naming product code DTR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20081—01
20092—00
20100—2443
20110—367
20120—016
20130—027
20140—066
20150—196
20160—060
20172—069
20181—075
20190—035
20202—033
20210—011
20222—023
20231—018
20241—08
20252—044
20261—2—

What is it indicated for?

The SURGIMEDICS®/TMP® Vision Cardioplegia Delivery System is intended to mix,

cool, warm, and deliver oxygenated blood cardioplegia solution during cardiopulmonary

bypass.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K964571: Vision Cardioplegia Delivery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K964571

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026